RxDoctor Payments Data

Eric Mallico, MD

Surgery · Salisbury, NCNPI 1790813863

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (47.9%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. W. L. Gore & Associates, Inc. accounts for 87.6% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2019 at $32,470 and has fallen 95.3% since, to $1,529 in 2025. Among surgery clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$78,446in general payments, 2019–2025

Across 300 payments — averaging $261.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • W. L. Gore & Associates, Inc.$69K
  • Johnson & Johnson$4K
  • Stryker$3K
  • Avanos Medical$723
  • Davol Inc.$699
  • Novo Nordisk$413
  • plus $2K from 12 others
$133,778in research payments, 2019–2025

Across 10 payments — averaging $13,378 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • W. L. Gore & Associates, Inc.$134K

What the payments were for

  • Consulting fees$17,82023%
  • Speaking & faculty fees$37,56548%
  • Travel & lodging$10,12313%
  • Food & beverage$12,93816%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$78,446 in reported general payments places this provider in the 95th percentile of 970 surgery providers in North Carolina.

See all surgery providers in North Carolina

Medicare billing

Part B allowed, 2024
$87,239
Medicare patients
133
Services billed
369

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide18$19,127
LinzessLinaclotide15$12,908
Sucralfate13$1,489
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen120$593
Promethazine Hcl19$484
Omeprazole39$396
Ondansetron Hcl30$202
Metoclopramide Hcl52$168
Pantoprazole Sodium26$140
Gabapentin15$111
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim18$68
Tramadol Hcl14$34
Topiramate13$22
Meloxicam14$18

Paid to pharmacies, not to this prescriber.

Other surgery in Salisbury

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →